KeyBanc Capital Markets’s $435 target on HCA

HCA HCA Healthcare

$390 → $435 (+12%) by Jul 2027

Overweight · lowers · said Jul 27, 2026 · 12-month default horizon

Open: judged on the close on Jul 27, 2027

The article this target came from

KeyBanc cuts HCA Healthcare stock price target on weaker HIX dynamics

Investing.com · Jul 27, 2026

KeyBanc lowered its price target on HCA Healthcare Inc shares to $435 from $475 while maintaining an Overweight rating on Monday.

KeyBanc Capital Markets’s track record → HCA Healthcare →

A fact about what KeyBanc Capital Markets published, as reported by Investing.com, not a recommendation from Dalsna Finance; KeyBanc Capital Markets is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.